Saturday, September 21, 2024
10:00AM – 11:00AM ET
Please note this virtual activity is 10:00AM Eastern, 9:00AM Central, 8:00AM Mountain and 7:00AM Pacific.
PRESENTING FACULTY
 |
Matthew D. Galsky, MD, FASCO Professor of Medicine Icahn School of Medicine at Mount Sinai Director, Genitourinary Medical Oncology Associate Director, Translational Research Tisch Cancer Institute New York, NY |
PROGRAM OVERVIEW
This virtually live activity focuses on improving care for patients with urothelial carcinoma with regard to effective risk assessment, individualized treatment selection, and adverse event management. This interactive program integrates didactic presentation with robust case-based discussions between you, your colleagues, and the expert faculty moderator to explore new treatment paradigms and clinical challenges in the treatment of bladder cancer.
TARGET AUDIENCE
This activity is intended for urologists, urologic oncologists, and multidisciplinary healthcare providers involved in the care of patients with bladder cancer.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Explain the latest therapeutic developments in the management of locally advanced and metastatic urothelial carcinoma in consideration of patient-specific factors
- Assess current clinical efficacy and safety data concerning the use of treatments in the management of urothelial carcinoma, both in frontline and later-line settings
- Relate current best practices in potential adverse event monitoring and management strategies in urothelial carcinoma
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected].
